Post has shared content
It takes less than 30 seconds to add your child information into #ZibdyHealth  and it will send up to 4 reminders for each vaccine. It is easier than you think.

Watch video tutorial for more info: Vaccinations with ZibdyHealth

Post has attachment
There is a lot of good stuff happening in the vaccine development, here I mention three of them. And since then I've learned about many many more.

Post has shared content
Thus, if you’re coming up with your own vaccine schedule, you’re increasing the risk of a minor, but kind of scary, adverse event–a febrile seizure. Why would one do that to gain no other benefit? That’s not clear to me.

Post has shared content
I hope this is all clear. Simple math tells us that the vaccine is much safer than getting whooping cough. Simple logic tell us that asymptomatic carriers do exist, and they don’t become so because of the vaccine. Understanding this is so easy that a baboon could do it. If they could talk. Or read.

Post has attachment
Thought I'd share this with you guys. I wrote this during my downtime between essays and exam, it was mainly inspired because we were revising about COPD. That and coupled with some rather odd statements I have heard from other nurses when the flu season starts.

Post has attachment

Post has attachment
Please try our new website!

Post has attachment

Post has attachment

Post has attachment
Emerging markets provide industry growth. Dr Jerry Sadoff, Chief Medical Officer at Crucell, joined us at the World Vaccine Congress in Washington, back in April to discuss the potential growth benefits of implementing breakthrough technologies in emerging markets.
 
Breakthrough technology could be very beneficial to emerging markets. For example, in the application of high density, low volume cell fermentation with or without disposables combined with advanced downstream purification; in the production of classical vaccine or new combinations for emerging markets taking advantage of lower cost goods with breakthrough technologies; or in the development of new vaccines to prevent diseases where there are no current vaccines: such as Malaria, HIV and TB.
 
Watch the presentation discover more about how breakthrough technology can serve the emerging markets and help solve the global burden of infectious diseases.
 
· Using breakthrough technology to allow for lower costs of goods reaching the emerging markets
 
· Can the vaccine industry remain at the forefront of innovation and keep prices at a global competitive level at the same time?

Visit our Website: http://www.terrapinn.com/2013/world-vaccine-congress-washington/index.stm
Read our blog: http://blogs.terrapinn.com/vaccinenation/
Follow us on Twitter:@vaccinenation
Join our Linkedin group: http://www.linkedin.com/groups/Vaccine-Nation-1351197  
Download the transcript here >
Wait while more posts are being loaded